亚托邦行程或亚托邦多发性疾病-当前研究概述
Iva Mrkić Kobal1,2, Davor Plavec2,3, Željka Vlašić Lončarić2,4
1Clinic for Pediatric Medicine Helena, Ulica kneza Branimira 71, 10000 Zagreb, Croatia.
Medicina (Kaunas, Lithuania)
|January 23, 2024
概括
阿托皮游行,一系列的过敏状况,并不是儿童过敏的唯一途径. 研究表明,更复杂的免疫路径影响疾病的发展,需要个性化的方法.
科学领域:
- 过敏和免疫学 过敏和免疫学
- 儿科过敏 儿科过敏
- 过敏性疾病中的免疫路径
背景情况:
- 阿托皮游行描述了儿童常见的过敏状况,包括阿托皮性皮肤炎,食物过敏,过敏性鼻炎和喘.
- 最初,阿托皮游行被认为是过敏疾病发展的主要模式.
- 最近的纵向研究揭示了过敏疾病进化的更复杂,多因素过程.
研究的目的:
- 为了审查传统的亚托皮游行概念.
- 在儿童过敏疾病发展中呈现替代模式.
- 强调预防,诊断和治疗亚托皮病的个性化策略.
主要方法:
- 对儿童过敏疾病的纵向研究的文献综述.
- 对导致过敏的免疫和病理机制的分析.
- 综合目前对亚托皮性疾病轨迹的理解.
主要成果:
- 阿托皮游行是过敏性疾病的几种潜在发展途径之一.
- 过敏性疾病的发展涉及到超越传统的亚托皮运动的多种免疫机制.
- 有证据表明,过敏状况的进展是非线性的和可变的.
结论:
- 儿童过敏性疾病的发展比亚托皮运动模型表明的要复杂得多.
- 了解不同轨迹对于有效的过敏管理至关重要.
- 个性化预防,诊断和治疗策略对于亚托皮性疾病至关重要.
更多相关视频
相关概念视频
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Genome-wide Association Studies-GWAS
13.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.4K
Asthma: Pathogenesis and Management
405
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
405
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
299
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
299
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K


